ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "COVID-19"

  • Abstract Number: L01 • ACR Convergence 2020

    Outcomes of COVID-19 Infection in Patients with Rheumatic Diseases in a Multicenter Healthcare System: A Comparative Cohort Study

    Naomi Serling-Boyd1, Kristin D'Silva1, Tiffany Hsu2, Xiaoqing Fu3, Rachel Wallwork4, April Jorge1, Yuqing Zhang1, Ellen Gravallese5, Hyon K. Choi6, Jeffrey Sparks7 and Zachary Wallace8, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Jamaica Plain, MA, 3Mass General Hospital, Boston, MA, 4Johns Hopkins Hospital, Baltimore, MA, 5Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 7Brigham and Women's Hospital, Boston, MA, 8Massachusetts General Hospital, Newton, MA

    Background/Purpose: The risk of poor outcomes from COVID-19 among rheumatic disease patients compared to the general population remains poorly understood. Filling this knowledge gap is…
  • Abstract Number: L02 • ACR Convergence 2020

    Risk Mitigating Behavior in People with Rheumatic Diseases or Psoriasis During the COVID-19 Pandemic Differ by Immunosuppressant Treatment Type: A Patient survey Study

    Mark Yates1, Satveer Mahil1, Sinead Langan2, Claudia De la cruz3, Paola diMeglio1, Nick Dand1, Zenas Yiu4, Kayleigh Mason4, Teresa Tsakok1, Freya Meynall5, Helen McAteer6, John Weinman1, Paolo Gisondi7, Luis Puig Sanz8, Richard Warren4, Francesca Capon1, Jullien Denis9, Tiago Torres10, Chris Griffiths4, Jonathan Barker1, Kimme Hyrich4, Andrew Cope1, Ian Bruce4, Iain McInnes11, Raj Sengupta12, Helena Marzo-Ortega13, Matthew Brown1, James Galloway1 and Catherine Smith1, 1King's College London, London, United Kingdom, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Santiago, Santiago, Chile, 4University of Manchester, Manchester, United Kingdom, 5Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, 6Psoriasis Association, London, United Kingdom, 7University of Verona, Verona, Italy, 8Hospital de la Santa Creu I Sant Pau, Barcelona, Spain, 9Hospices Civils de Lyon, Lyon, France, 10University of Porto, Porto, Portugal, 11University of Glasgow, Glasgow, United Kingdom, 12Royal United Hospitals Bath, Bath, United Kingdom, 13University of Leeds, Leeds, United Kingdom

    Background/Purpose: Clinician-reported registry data suggest that use of biologics in people with immune-mediated inflammatory diseases (IMIDs) is associated with a lower risk of adverse COVID-19…
  • Abstract Number: L05 • ACR Convergence 2020

    DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic

    Kaleb Michaud1, Sofia Pedro2, Kristin Wipfler3, Ekta Agarwal4 and Patricia Katz5, 1University of Nebraska Medical Center and Forward, the National Databank for Rheumatic Diseases, Omaha, NE, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4Pfizer inc, Princeton Jct, NJ, 5UCSF, Mill Valley, CA

    Background/Purpose: To understand medication and clinical care changes by patients with RA during the first 3 months (March through May 2020) of the COVID-19 pandemic…
  • Abstract Number: L07 • ACR Convergence 2020

    Tocilizumab for COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    John Stone1, 1Massachusetts General Hospital, Boston, MA

    Background/Purpose: The efficacy of interleukin-6 receptor blockade in hospitalized COVID-19 patients not on mechanical ventilation is unclear.Methods: We performed a randomized, double-blind, placebo-controlled trial in…
  • Abstract Number: 0003 • ACR Convergence 2020

    Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations

    Quinn Pritchett1, Rebecca Overbury1, Dorota Lebiedz-Odrobina1, Julie Thomas1, Tawnie Braaten2, Stacey Clardy1, Marc Elgort3, Emily Spivak1, Patricia Slev3, Lisa Peterson3 and Tracy Frech4, 1University of Utah, Salt Lake City, UT, 2University of Utah, Salt Lake City, 3ARUP, Salt Lake City, UT, 4University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT

    Background/Purpose: The COVID-19 pandemic is especially terrifying for patients on immunosuppression for autoimmune disease. With the exception of social isolation, experts do not have clear…
  • Abstract Number: 0021 • ACR Convergence 2020

    Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned

    Dominique Kinnett-Hopkins1, Linda Ehrlich-Jones2, Holly Milaeger3, Alanna Kenney3, Lorena Rosiles3 and Rosalind Ramsey-Goldman4, 1Northwestern University, Chicago, IL, 2Shirley Ryan AbilityLab, Chicago, 3Northwestern University, Chicago, 4Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: The coronavirus disease 2019 (COVID-19) global pandemic has drastically impacted the health system and the research community. Many research institutions and funding agencies recommended…
  • Abstract Number: 0464 • ACR Convergence 2020

    Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Preliminary Results from the REUMAVID Study

    Marco Garrido-Cumbrera1, Helena Marzo-Ortega2, José Correa-Fernández3, Sergio Sanz-Gomez4, Laura Christen5 and Victoria Navarro-Compán6, 1Health & Territory Research (HTR), Universidad de Sevilla / Spanish Federation of Spondyloarthritis Associations, Sevilla, Spain, 2The University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK, Leeds, United Kingdom, 3Health & Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain, 4Health & Territory Research, Seville, Spain, 5Novartis Pharma AG, Basel, Switzerland, 6Hospital Universitario La Paz IdiPaz, Madrid, Pais Vasco, Spain

    Background/Purpose: The COVID-19 pandemic is an unprecedented public health crisis affecting people worldwide, including those with rheumatic and musculoskeletal diseases (RMDS).  REUMAVID aims to assess…
  • Abstract Number: 0607 • ACR Convergence 2020

    The Evolution of Rheumatologist’s Practice in Response to the COVID19 Pandemic

    Maria Bacalao1, Kathryn Dao2 and John Cush2, 1UT Southwestern, Dallas, TX, 2University of Texas Southwestern Medical School, Dallas, TX

    Background/Purpose: The COVID19 pandemic was a turning point for Rheumatology. This survey of rheumatologists (rheums) assessed its impact on care delivery, patient counseling and drug…
  • Abstract Number: 0645 • ACR Convergence 2020

    Prevalence and Clinical Features of COVID-19 in a Large Cohort of 199 Patients with Sarcoidosis

    Anne-Claire Desbois1, Cindy Marques1, Leila Lefèvre1, Serge Barmo1, Camille Lorenzo1, Mathilde Leclercq1, Gaëlle Leroux1, Chloé Comarmond1, Catherine Chapelon-Abric1, Fanny Domont1, David Saadoun1 and Patrice Cacoub1, 1AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, F-75013, Paris, France, Centre national de références Maladies Autoimmunes et systémiques rares et Maladies Autoinflammatoires rares, Paris, France

    Background/Purpose: To investigate the prevalence, clinical features and outcomes of coronavirus disease 2019 (COVID-19) among sarcoidosis patients.Methods: We retrospectively collected clinical features, treatments and outcomes…
  • Abstract Number: 1469 • ACR Convergence 2020

    Characteristics of Adult Patients with Rheumatic Diseases During the COVID-19 Pandemic: Data from an International Patient Survey

    Jonathan Hausmann1, Kevin Kennedy2, Salman Surangiwala3, Maggie Larche4, Mitchell Levine2, Jean Liew5, Zachary Wallace6 and Emily Sirotich4, 1Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 2McMaster University, Hamilton, Canada, 3Queen’s School of Medicine, Kingston, Canada, 4McMaster University, Hamilton, ON, Canada, 5University of Washington, Seattle, WA, 6Massachusetts General Hospital, Newton, MA

    Background/Purpose: Patients with rheumatic diseases are at increased risk of infection due to immune dysregulation and the use of immunosuppression.  It is unknown whether they…
  • Abstract Number: 1962 • ACR Convergence 2020

    Utilization of Telehealth Among Patients with Rheumatic Diseases in the Early Months of the COVID-19 Pandemic

    Kristin Wipfler1, Yomei Shaw2, Teresa Simon3, Adam Cornish1, Patricia Katz4 and Kaleb Michaud5, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, East Lansing, MI, 3Bristol-Myers Squibb Company (at time of analysis), Princeton, NJ, 4University of California, San Francisco, Novato, CA, 5University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Many health care providers replaced in-person clinical visits with telehealth visits or expanded their telehealth offerings due to the COVID-19 pandemic. We sought to…
  • Abstract Number: 0004 • ACR Convergence 2020

    The Impact of the COVID-19 Pandemic on Patients with Chronic Rheumatic Diseases: A Study in 15 Arab Countries

    Nelly Ziade1, Lina El Kibbi2, Ihsane Hmamouchi3, Nizar Abdulateef4, Hussein Halabi5, Wafa Hamdi6, Fatemah Abutiban7, Manal el Rakawi8, Mervat Eissa9 and Basel Masri10, 1Saint-Joseph University, Beirut, Lebanon, Beirut, Lebanon, 2Specialized Medical Center, Riyadh, Saudi Arabia, Riyadh, Saudi Arabia, 3Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, Rabat, Morocco, 4Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Iraq, Baghdad, Iraq, 5King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia, Jeddah, Saudi Arabia, 6Department of Rheumatology, Kassab Institute of orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia, Tunis, Tunisia, 7Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah hospital, State of Kuwait, Jahra, Kuwait, 8Departement of Rheumatology, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria, Blida, Algeria, 9Rheumatology Department, Cairo University, Cairo, Egypt, Cairo, Egypt, 10Jordan Hospital, Amman, Jordan, Amman, Jordan

    Background/Purpose: To evaluate the impact of the Coronavirus Disease 2019 pandemic (COVID-19) on the access to rheumatology care for patients with chronic rheumatic diseases in…
  • Abstract Number: 0028 • ACR Convergence 2020

    Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients

    Valerie Aloush1, Avital Gurfinkel2, Noam Shachar3, Jacob Ablin1 and Odelia Elkana4, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Academic College TelAviv- Jaffa, Tel Aviv, Israel, 3Acamedic College Tel Aviv- Jaffa, Tel Aviv, Israel, 4Academic College Tel Aviv Jaffa, Tel Aviv, Israel

    Background/Purpose: Fibromyalgia is a chronic pain disorder, characterized by abnormal pain processing in the central nervous system. Acute or chronic stress may trigger or aggravate…
  • Abstract Number: 0465 • ACR Convergence 2020

    The COVID-19 Pandemic and Its Effect on Patients with Chronic Rheumatologic Disease Regarding the Value of Vaccination Recommendations

    Rebecca Overbury1, Gregory Stoddard2 and Tracy Frech3, 1University of Utah and Primary Children's Hospital, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT, 3University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT

    Background/Purpose: Vaccinations are an important component of care in rheumatology as many patients are immunocompromised by treatment therapies. Patients are sometimes reticent to receive recommended…
  • Abstract Number: 0610 • ACR Convergence 2020

    Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak

    Kent Kwas Huston1, Nehad Soloman2, Janna Radtchenko3, Simon Helfgott4, Jasvinder Singh5 and Colin Edgerton6, 1Kansas City Physician Partners, Kansas City, MO, 2Arizona Arthritis & Rheumatology Associates, P.C., Peoria, AZ, 3Trio Health, Louisville, CO, 4BWH- HMS, Boston, MA, 5University of Alabama at Birmingham, Birmingham, AL, 6Articularis Healthcare, Summerville, SC

    Background/Purpose: Patients (pts) with autoimmune diseases managed by rheumatologists represent vulnerable population with risk of serious complications if exposed to novel coronavirus SARS-CoV2. The first…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.